Tjokosela was particularly interested in the interaction between HIV and TB drugs when administered together. Tjokosela was also involved in the development of a paediatric dosing tool using Shiny software that is able to predict exposure for a generic drug. The tool can also be used to simulate entire pharmacokinetic profiles by using a drug-specific population pharmacokinetic model.